Clinical outcomes following identification of an incidental p53 signature in the fallopian tube

Clinical outcomes following identification of an incidental p53 signature in the fallopian tube

Fallopian tube pathology in patients with BRCA1 and BRCA2 mutations suggests a possible pathway to high grade serous ovarian carcinoma originates with a p53 signature, which is thought to represent a potential precursor to serous tubal intraepithelial carcinoma (STIC). The clinical implications of a...

Full description

Bibliographic Details
Main Authors: Emily C. MacARTHUR, Mackenzy RADOLEC, T. Rinda SOONG, Esther ELISHAEV, Ronald BUCKANOVICH, Sarah E. TAYLOR, Jamie LESNOCK
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Gynecologic Oncology Reports
Subjects:
serous tubal intraepithelial carcinoma (STIC)
Cancer-Risk
Benign gynecology
Serous ovarian cancer
Precursor lesion
Pathology
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578924000389

Internet

http://www.sciencedirect.com/science/article/pii/S2352578924000389

Similar Items